Site Menu

Over 14 Million COVID-19 Tests Performed

Aegis Sciences Corporation Study Shows Widespread Distribution of Xylazine Read More.

Aegis Sciences Corporation
  • Our Services
    • PainComp
    • InterACT Rx
      • Clinical Studies
    • Infectious Disease Testing
    • Monkeypox Testing
    • ACURISE ID
    • Novel Psychoactive Substance Testing
      • Xylazine
      • 2022 NPS Summary
    • BioDetect™
    • KardiAssure
    • Prenatal Testing
    • Sports Testing
    • Aegis FLEX Testing
    • COVID-19 Testing
      • COVID-19 Diagnostic Testing FAQs
      • Patient Portal
    • FLUID
  • Resources
    • Clinical Update
      • Novel Psychoactive Substances: What is Xylazine?
    • Webinars
    • Clinical Reference Guide
    • News
    • Publications
    • InPractice Clinical Insights
    • Testimonials
  • Work With Us
  • Our Team
    • Aegis Provides Clarity
    • About Aegis
    • Quality
    • Expert Team
    • Executive Leadership
  • Client Login
  • Pay My Bill
  • Home
Aegis Sciences Corporation

CONTACT

515 Great Circle Road
Nashville, TN 37228

800.533.7052
info@aegislabs.com

HELPFUL LINKS

  • HIPAA Notice of Privacy Practices
  • Nondiscrimination Notice
  • EEO Policy
  • Annual Notice
  • Privacy Policy
  • Terms of Use
  • Compliance Hotline
  • Client Satisfaction Survey
  • Collection Instructions
  • Work With Us

© Copyright 2023 Aegis Sciences Corporation